Ladenburg Thalmann Financial Services’s Biolase, Inc. BIOL Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio BIOL Stock Details BIOL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Hold	0	–	–	–	5547
2019 Q3	–	Hold	0	–	–	–	5179
2019 Q2	–	Hold	0	–	–	–	5177
2019 Q1	–	Hold	0	–	–	–	5136
2018 Q4	–	Hold	0	–	–	–	5115
2018 Q3	–	Sell	-1	Closed	-$4K	–	5061
2018 Q2	$1K	Buy	+1	New	+$3.77K	﹤0.01%	5035
2018 Q1	–	Hold	0	–	–	–	5035
2017 Q4	–	Hold	0	–	–	–	4947
2017 Q3	–	Hold	0	–	–	–	4706
2017 Q2	–	Hold	0	–	–	–	4508
2017 Q1	–	Hold	0	–	–	–	4410
2016 Q4	–	Hold	0	–	–	–	4346
2016 Q3	–	Hold	0	–	–	–	4187
2016 Q2	–	Hold	0	–	-$1K	–	4863
2016 Q1	–	Hold	0	–	–	–	4575
2015 Q4	–	Hold	0	–	–	–	4561
2015 Q3	–	Hold	0	–	–	–	4474
2015 Q2	–	Hold	0	–	–	–	4546
2015 Q1	–	Hold	0	–	–	–	4467
2014 Q4	–	Hold	0	–	–	–	4089
2014 Q3	–	Hold	0	–	–	–	3703
2014 Q2	–	Hold	0	–	–	–	3804
2014 Q1	–	Hold	0	–	–	–	3538
2013 Q4	–	Hold	0	–	–	–	3529
2013 Q3	–	Hold	0	–	–	–	3596
2013 Q2	–	Hold	0	–	–	–	3350

Other funds holding BIOL

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Ladenburg Thalmann Financial Services's BIOL Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Biolase, Inc. (BIOL) position steady in Q4 2019 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5547.

Ladenburg Thalmann Financial Services first reported a position in BIOL in Q2 2018 and has held it in 1 quarter since. The position peaked at $1K in Q2 2018. 19 funds tracked by Wall St. Rank hold BIOL as of Q4 2019.

Ladenburg Thalmann Financial Services held 0 shares of Biolase, Inc. worth $0 as of Q4 2019.
Ladenburg Thalmann Financial Services left its Biolase, Inc. share count unchanged in Q4 2019.
Biolase, Inc. made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5547 holding.
Ladenburg Thalmann Financial Services first reported a position in Biolase, Inc. in Q2 2018 and has held it in 1 quarter since.
Ladenburg Thalmann Financial Services's Biolase, Inc. position peaked at $1K in Q2 2018.
19 funds tracked by Wall St. Rank held Biolase, Inc. as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.